￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Crizotinib Pfizer production background and brand value analysis

2026-02-01 22:25:32

Check Details
Tucatinib/tucatinib promotes first-line maintenance in advanced HER2+ breast cancer

2026-02-01 22:25:32

Check Details
How effective is Alpelisib in the treatment of breast cancer?

2026-02-01 22:25:32

Check Details
Precautions for using aprocitentan and care suggestions in daily life

2026-02-01 22:25:32

Check Details
When will fostatinib/fotantinib be released on the market?

2026-02-01 22:25:32

Check Details
Precautions and tips for taking Seputinib/Serpatinib (Ruitu)

2026-02-01 22:25:32

Check Details
Tilpotide/Tisiparatide (Mufengda) indications and main treatment range of diseases

2026-02-01 22:25:32

Check Details
Analysis of the relationship between the names and pharmacodynamics of pitobrutinib/pirtobrutinib and jepali

2026-02-01 22:25:32

Check Details
Analysis of clinical therapeutic effects and efficacy evaluation of talazoparib (Tazena)

2026-02-01 22:25:32

Check Details
Detailed list of contraindications for Maribavir/Yitaizhi

2026-02-01 22:25:32

Check Details
Explanation of why some patients are not recommended to take Crizotinib (Xalkori)

2026-02-01 22:25:32

Check Details
Inavolisib’s mechanism of action and target analysis

2026-02-01 22:25:32

Check Details
Category
相关知识